C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 1/20 (2006.01) A61K 39/02 (2006.01) A61K 39/112 (2006.01) A61P 31/04 (2006.01) C12N 1/36 (2006.01)
Patent
CA 2131231
Use of at least one attenuated immunogenic salmonella live vaccine strain comprising a marker (envelope marker) having a sensitivity towards macrolide antibiotics, for the production of a live vaccine for a specific host which, in the case of an infection caused by the specific host, facilitates an effective therapeutical treatment of the infected host by means of macrolides.
Utilisation d'au moins une souche vaccinale vivante atténuée immunogène de Salmonella comprenant un marqueur (marqueur à enveloppe) sensible aux macrolides, pour la production d'un vaccin vivant contre un hôte spécifique qui, dans le cas d'une infection causée par l'hôte spécifique, facilite le traitement thérapeutique efficace de l'hôte infecté au moyen de macrolides.
Beer Jorg
Linde Klaus
Randhagen Barbel
Fetherstonhaugh & Co.
Lohmann Animal Health Gmbh & Co. Kg
Tad Pharmazeutisches Werk Gmbh
LandOfFree
Salmonella live vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salmonella live vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salmonella live vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2002989